OTLK icon

Outlook Therapeutics

75 hedge funds and large institutions have $29.6M invested in Outlook Therapeutics in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 19 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$3.59M
2 +$205K
3 +$119K
4
Goldman Sachs
Goldman Sachs
New York
+$100K
5
Bank of America
Bank of America
North Carolina
+$59.8K

Top Sellers

1 -$163K
2 -$159K
3 -$130K
4
Renaissance Technologies
Renaissance Technologies
New York
-$61K
5
GL
Graypoint LLC
New York
-$46K
Name Holding Trade Value Shares
Change
Change in
Stake
51
$17.8K
52
$17K
53
$16.5K
54
$16.4K
55
$16.3K
56
$15.4K
57
$15.1K
58
$13.4K
59
$12.8K
60
$11.4K
61
$10.8K
62
$10.8K
63
$10.8K
64
$10.8K
65
$10.8K
66
$10.8K
67
$8K
68
$7.55K
69
$2.16K
70
$1.4K
71
$1.35K
72
$862
73
$216
74
$216
75
$5